NasdaqGS - Delayed Quote USD

Nuvalent, Inc. (NUVL)

73.32
+2.32
+(3.27%)
At close: May 16 at 4:00:00 PM EDT
73.32
0.00
(0.00%)
After hours: May 16 at 4:07:22 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
322,592
280,368
149,492
86,108
45,817
Operating Income
-322,592
-280,368
-149,492
-86,108
-45,817
Net Non Operating Interest Income Expense
41,644
38,316
23,273
4,254
--
Other Income Expense
1,167
-17,940
--
4,254
-521
Pretax Income
-300,318
-259,992
-126,219
-81,854
-46,338
Tax Provision
538
764
0
0
--
Net Income Common Stockholders
-300,856
-260,756
-126,219
-81,854
-46,338
Diluted NI Available to Com Stockholders
-300,856
-260,756
-126,219
-81,854
-46,338
Basic EPS
-4.42
--
-2.17
-1.65
-2.13
Diluted EPS
-4.42
--
-2.17
-1.65
-2.13
Basic Average Shares
68,273.05
--
58,223.34
49,668.86
21,783.75
Diluted Average Shares
68,273.05
--
58,223.34
49,668.86
21,783.75
Total Operating Income as Reported
-322,592
-280,368
-149,492
-86,108
-45,817
Total Expenses
322,592
280,368
149,492
86,108
45,817
Net Income from Continuing & Discontinued Operation
-300,856
-260,756
-126,219
-81,854
-46,338
Normalized Income
-300,856
-260,756
-126,219
-81,854
-46,338
Interest Income
41,644
38,316
23,273
4,254
--
Net Interest Income
41,644
38,316
23,273
4,254
--
EBIT
-322,592
-280,368
-149,492
-86,108
-45,817
EBITDA
-322,592
-280,368
-149,492
-86,108
-45,817
Net Income from Continuing Operation Net Minority Interest
-300,856
-260,756
-126,219
-81,854
-46,338
Normalized EBITDA
-322,592
-280,368
-149,492
-86,108
-45,817
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

APGE Apogee Therapeutics, Inc.
40.62
-0.05%
 
EWTX Edgewise Therapeutics, Inc.
14.78
+2.28%
 
KYMR Kymera Therapeutics, Inc.
30.25
+0.77%
 
BPMC Blueprint Medicines Corporation
101.69
+2.21%
 
CGEM Cullinan Therapeutics, Inc.
7.50
+3.59%
 
MRUS Merus N.V.
41.56
+3.69%
 
RVMD Revolution Medicines, Inc.
39.54
+0.25%
 
ACLX Arcellx, Inc.
58.78
+0.56%
 
PCVX Vaxcyte, Inc.
31.85
+3.07%
 
NUVB Nuvation Bio Inc.
2.2600
+0.89%